These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11166778)

  • 41. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
    Skrzypek A; Nessler J
    Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of cellular fibronectin in diabetes.
    Kanters SD; Banga JD; Algra A; Frijns RC; Beutler JJ; Fijnheer R
    Diabetes Care; 2001 Feb; 24(2):323-7. PubMed ID: 11213886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity.
    Cucuianu M; Bodizs G; Duncea I; Colhon D
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):779-85. PubMed ID: 9034558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
    JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in plasma fibronectin levels in thyroid diseases.
    Shirakami A; Hirai Y; Takeichi T; Nishino H; Inomoto T; Watanabe S; Shigekiyo T; Kawauchi S; Saito H; Saito S
    Horm Metab Res; 1986 May; 18(5):345-8. PubMed ID: 3755115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma fibronectin level in patients with moyamoya disease].
    Sasaki O; Tanaka R; Koike T; Takeuchi S; Takizawa T; Ishi R; Arai H
    No To Shinkei; 1987 Nov; 39(11):1069-73. PubMed ID: 3442638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-dependent changes in extra-domain A-fibronectin concentration and relative amounts of fibronectin-fibrin complexes in plasma of patients with peripheral arterial disease after endovascular revascularisation.
    Pupek M; Krzyżanowska-Gołąb D; Kotschy D; Witkiewicz W; Kwiatkowska W; Kotschy M; Kątnik-Prastowska I
    Int Wound J; 2018 Aug; 15(4):649-659. PubMed ID: 29536628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Rasmussen KL
    Atherosclerosis; 2016 Dec; 255():145-155. PubMed ID: 28340945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
    Li M; Xu A; Lam KS; Cheung BM; Tse HF
    Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic analysis of salt-sensitive hypertension in Dahl rats reveals a link between cardiac fibrosis and high cholesterol.
    Wendt N; Schulz A; Qadri F; Bolbrinker J; Kossmehl P; Winkler K; Stoll M; Vetter R; Kreutz R
    Cardiovasc Res; 2009 Feb; 81(3):618-26. PubMed ID: 18824493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
    Langes K; Volk C; Schneider MA; Koschyk DH; Rinninger F; Nienaber CA
    Z Kardiol; 1995 Mar; 84(3):180-9. PubMed ID: 7732710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan.
    Satoh M; Ohkubo T; Asayama K; Murakami Y; Sakurai M; Nakagawa H; Iso H; Okayama A; Miura K; Imai Y; Ueshima H; Okamura T;
    Hypertension; 2015 Mar; 65(3):517-24. PubMed ID: 25601929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A possible mechanism of the hypotensive effect of laser irradiation in patients with ischemic heart disease with arterial hypertension].
    Vasil'ev AP; Strel'tsova NN
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (5):17-20. PubMed ID: 11785330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.
    Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
    Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of pericardial and plasma ghrelin levels in patients with ischemic and non-ischemic heart disease.
    Sax B; Merkely B; Túri K; Nagy A; Ahres A; Hartyánszky I; Hüttl T; Szabolcs Z; Cseh K; Kékesi V
    Regul Pept; 2013 Sep; 186():131-6. PubMed ID: 23994275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Plasma lipids oxidation in patients with occlusive atherosclerosis of lower extremities and ischemic heart disease].
    Dadvani SA; Syrkin AL; Azizova OA; Shcherbiuk AN; Dumikian ASh; Artiukhina EG; Ul'ianov DA; Solov'eva NP; Dudnik LB
    Kardiologiia; 2005; 45(4):55-60. PubMed ID: 15940193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.
    Durakoğlugil ME; Ayaz T; Kocaman SA; Kırbaş A; Durakoğlugil T; Erdoğan T; Çetin M; Şahin OZ; Çiçek Y
    Anatol J Cardiol; 2015 Jul; 15(7):577-85. PubMed ID: 25538000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease.
    Bütün II; Ekmekçi H; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):308-12. PubMed ID: 17636193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dynamics of inflammatory cytokines levels in patients with different forms of ischemic heart disease].
    Mazurov VI; Stolov SV; Linetskaia NE
    Klin Med (Mosk); 1999; 77(11):23-7. PubMed ID: 10635627
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of anti-arteriosclerosis diet, containing soya protein isolate and omega-3 polyunsaturated fatty acids on the activity of mononuclear and platelet lysosomal hydrolases in patients with hypertension and ischemic heart disease].
    Samsonov MA; Pogozhaeva AV; Vasilév AV; Bogdanova SN; Pokrovskaia GR; Varsanovich EA; Orlova LA
    Vopr Pitan; 1993; (1):14-8. PubMed ID: 7975402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.